Cardiovascular diseases (CVDs) are the leading cause of death and morbidity worldwide.
Atherosclerotic situations such as acute myocardial infarction (MI) and stroke are still major …

Highlights•The application of nanomaterials to the treatment of cardiovascular and other
disorders has lagged the development of materials for use in oncology.•The inclusion of cell …

Recent years brought about a widespread interest in the potential applications of
nanotechnology for the diagnostics and the therapy of human diseases. With its promise of …

Cardiovascular diseases claim a number of lives globally; many of which are preventable.
With the increase in diets that consist of high saturated fat, salt, and sugar, people often …

Cardiovascular diseases are a major cause of disability and they are currently responsible
for a significant number of deaths in a large percentage of the world population. A large …

Cardiovascular disease (CVD) is the leading cause of death worldwide. CVD includes a
group of disorders of the heart and blood vessels such as myocardial infarction, ischemic …

Atherosclerosis is a systemic pathophysiological condition contributing to the development
of majority of polyvascular diseases. Nanomedicine is a novel and rapidly developing …

Nanoparticles are exclusively suitable for studying and developing potential therapies
against cardiovascular diseases (CVD) because of their size, fine-tunable properties, and …

Nanomedicine is using nanotechnology in the medical application, which could range from
medical use of nanomaterials in drug delivery and bio-imaging to development of nano …

Almost a third of all fatalities may be attributed to cardiovascular disease (CVD), making it a
primary cause of mortalities worldwide. Better diagnostic tools and secure, non-invasive …